Randomized controlled study of high-dose metoclopramide and dexamethasone in the prevention of CDDP-induced emesis
Umehara, H.; Sawamura, N.; Takahashi, S.; Kusano, H.; Yokoyama, S.; Suemasu, K.
Gan to Kagaku Ryoho. Cancer and ChemoTherapy 13(5): 1996-1998
1986
ISSN/ISBN: 0385-0684 PMID: 3010886 Document Number: 277482
Document emailed within 1 workday
Related Documents
Heron, J.F. 1995: Single-agent oral granisetron for the prevention of acute cisplatin-induced emesis: a double-blind, randomized comparison with granisetron plus dexamethasone and high-dose metoclopramide plus dexamethasone Seminars in Oncology 22(4 Suppl. 10): 24-30Numbenjapon, T.; Sriswasdi, C.; Mongkonsritragoon, W.; Leelasiri, A.; Prayoonwiwat, W. 2002: Comparative study of low-dose oral granisetron plus dexamethasone and high-dose metoclopramide plus dexamethasone in prevention of nausea and vomiting induced by CHOP-therapy in young patients with non-Hodgkin's lymphoma Journal of the Medical Association of Thailand 85(11): 1156-1163
Bhatia, A.; Tripathi, K.D.; Sharma, M. 2003: Comparison of ondansetron with metoclopramide in prevention of acute emesis associated with low dose & high dose cisplatin chemotherapy Indian Journal of Medical Research 118: 33-41
van Groeningen, C.J.; Gall, H.E.; Simons, K.A.; van Loenen, A.C.; Knobf, M.K.; Nauta, J.; Vermorken, J.B.; Pinedo, H.M. 1989: Comparison of two different high doses of metoclopramide in the prevention of chemotherapy-induced emesis Netherlands Journal of Medicine 35(5-6): 283-294
Chevallier, B. 1990: Efficacy and safety of granisetron compared with high-dose metoclopramide plus dexamethasone in patients receiving high-dose cisplatin in a single-blind study. the Granisetron Study Group European Journal of Cancer 26(Suppl 1): S33-S36
Manusirivithaya, S.; Chareoniam, V.; Isariyodom, P.; Sungsab, D. 2001: Comparison of ondansetron-dexamethasone-lorazepam versus metoclopramide-dexamethasone-lorazepam in the control of cisplatin induced emesis Journal of the Medical Association of Thailand 84(7): 966-972
Ko-Iam, W.; Sandhu, T.; Paiboonworachat, S.; Pongchairerks, P.; Junrungsee, S.; Chotirosniramit, A.; Chotirosniramit, N.; Chandacham, K.; Jirapongcharoenlap, T. 2015: Metoclopramide, versus its combination with dexamethasone in the prevention of postoperative nausea and vomiting after laparoscopic cholecystectomy: a double-blind randomized controlled trial Journal of the Medical Association of Thailand 98(3): 265-272
Tantipalakorn, C.; Srisomboon, J.; Thienthong, H.; Pantusart, A.; Suprasert, P.; Saereesongkhun, C.; Eamtang, S.; Sutthichat, A.; Pautad, N. 2004: Comparison of oral versus intravenous ramosetron in prevention of acute cisplatin-induced emesis: a randomized controlled trial Journal of the Medical Association of Thailand 87(2): 119-125
Garcia-del-Muro, X.; Vadell, C.; Pérez Manga, G.; Bover, I.; Rifá, J.; Beltrán, M.; Barros, M.M.; Germá, J.R.; Fabregat, X.; Moreno, V.; Salvador, A.; Viladiu, P. 1998: Randomised double-blind study comparing tropisetron alone and in combination with dexamethasone in the prevention of acute and delayed cisplatin-induced emesis European Journal of Cancer 34(1): 193-195
Agostinucci, W.A.; Gannon, R.H.; Golub, G.R.; Martin, R.S.; Schauer, P.K.; Dinonno, E.B. 1988: Continuous i.v. infusion versus multiple bolus doses of metoclopramide for prevention of cisplatin-induced emesis Clinical Pharmacy 7(6): 454-457
Voravud, N.; Suwanrusmee, H. 2000: Phase II trial of tropisetron and dexamethasone in the prevention of cisplatin-induced emesis Journal of the Medical Association of Thailand 83(6): 668-675
Abad-Esteve, A.; Rosell, R.; Moreno, I.; Monrás, P.; Fernández, C.; Serichol, M.; Clotet, M.; Ribas Mundó, M. 1986: Evaluation of an antiemetic regimen with a high-dose metoclopramide, dexamethasone and diphenhydramine combination in chemotherapy regimens with cisplatin Medicina Clinica 87(19): 796-798
Hellenbrecht, D.; Saller, R. 1986: Dose-response relationships of the objective and subjective antiemetic effects and of different side effects of metoclopramide against cisplatin induced emesis Arzneimittel-Forschung 36(12): 1845-1849
Usnarska-Zubkiewicz, L.; Kotlarek-Haus, S.; Wiela-Hojeńska, A.; Orzechowska-Juzwenko, K.; Gabryś, K. 1990: Comparison of the effectiveness of metoclopramide and dexamethasone in the prevention of cytostatic-induced vomiting Polski Tygodnik Lekarski 45(32-33): 665-668
Kikuchi, K.; Wakui, A.; Shimizu, H.; Kunii, Y. 1990: Randomized controlled study on chemotherapy with 5-FD, ADM plus CDDP in advanced gastric carcinoma Gan to Kagaku Ryoho. Cancer and ChemoTherapy 17(4 Part 1): 655-662
Chuenkongkaew, W.; Chirapapaisan, N. 2002: A prospective randomized trial of megadose methylprednisolone and high dose dexamethasone for traumatic optic neuropathy Journal of the Medical Association of Thailand 85(5): 597-603
Cupissol, D.R.; Serrou, B.; Caubel, M. 1990: The efficacy of granisetron as a prophylactic anti-emetic and intervention agent in high-dose cisplatin-induced emesis European Journal of Cancer 26(Suppl 1): S23-S27
Klockgether-Radke, A.; Feldmann, M.; Braun, U.; Mühlendyck, H. 1992: Droperidol versus metoclopramide. Prevention of emesis following strabismus surgery in children Der Anaesthesist 41(5): 254-259
Marty, M. 1990: A comparative study of the use of granisetron, a selective 5-HT3 antagonist, versus a standard anti-emetic regimen of chlorpromazine plus dexamethasone in the treatment of cytostatic-induced emesis. the Granisetron Study Group European Journal of Cancer 26(Suppl 1): S28-S32
Chiou, T.J.; Wei, C.H.; Hsieh, R.K.; Fan, F.S.; Liu, J.H.; Chen, P.M. 1995: Comparison of intravenous granisetron with metoclopramide in the treatment of chemotherapy-induced emesis Zhonghua Yi Xue Za Zhi 56(1): 23-30